IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.

Saved in:
Bibliographic Details
Title: IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.
Authors: Kudo-Saito, Chie1 (AUTHOR) ckudo@ncc.go.jp, Imazeki, Hiroshi1,2 (AUTHOR), Nagashima, Kengo3 (AUTHOR), Shoji, Hirokazu2 (AUTHOR), Tsugaru, Kai4 (AUTHOR), Takahashi, Naoki5 (AUTHOR), Kawakami, Takeshi6 (AUTHOR), Amanuma, Yusuke7 (AUTHOR), Wakatsuki, Takeru8 (AUTHOR), Okano, Naohiro9 (AUTHOR), Narita, Yukiya10 (AUTHOR), Yamamoto, Yoshiyuki11 (AUTHOR), Kizawa, Rika12 (AUTHOR), Muro, Kei10 (AUTHOR), Ichikawa, Hitoshi13 (AUTHOR), Boku, Narikazu2,14 (AUTHOR)
Source: Journal of Translational Medicine. 10/17/2025, Vol. 23 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-025-07145-3